| Name | Title | Contact Details |
|---|
Pathways Health Center For is a Sarnia, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Our technology has been tested by top institutions and is used in hundreds of facilities throughout the world. We developed a technology that significantly reduces unhealthy contaminants. This technology quickly and effectively decreases airborne viruses, bacteria, particulates, mold, VOCs and odors. It cleans the air and creates a healthier environment.
The Canadian College of Neuropsychopharmacology is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Med ISP is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.